The impact of drug coverage on COX-2 inhibitor use in Medicare.
Doshi
Jalpa A
JA
Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA. jdoshi@mail.med.upenn.edu
Brandt
Nicole
N
Stuart
Bruce
B
D000368:Aged; D000369:Aged, 80 and over; D016861:Cyclooxygenase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008297:Male; D006278:Medicare; D014481:United States
D016861:Cyclooxygenase Inhibitors